Rationale: Abnormal behavior of the cardiac ryanodine receptor (RyR2) has been linked to cardiac arrhythmias and heart failure (HF) after myocardial infarction (MI). It has been proposed that protein kinase A (PKA) hyperphosphorylation of the RyR2 at a single residue, Ser-2808, is a critical mediator of RyR dysfunction, depressed cardiac performance, and HF after MI.
M yocardial infarction (MI)
is a major cause of left ventricular dysfunction that leads to heart failure (HF) and arrhythmogenic sudden cardiac death. 2 The development of HF after MI involves remodeling at the molecular, cellular, and organ levels and is characterized by ventricular dilatation, elevated systolic wall stress, and poor cardiac pump function. Dysregulated intracellular Ca 2ϩ handling plays a major role in the pathophysiology of contractile, electrophysiological, and structural abnormalities that evolve after MI. 3 There are alterations in the abundance and phosphorylation state of almost all Ca 2ϩ regulatory proteins in the failing heart. 4 -5 Collectively, these changes produce alterations in diastolic and systolic Ca 2ϩ and diminished responses to sympathetic regulatory stimulation. 6 -7 There is some evidence, primarily from the Marks laboratory, 8, 9 that hyperphosphorylation of the Ca 2ϩ release channel (Ryanodine receptor; RyR2) plays a significant independent role in the altered Ca 2ϩ regulation of the heart after MI. This idea was tested in the current study.
Cardiac myocyte contraction occurs when the action potential activates voltage-gated L-type Ca 2ϩ channels (LTCCs) 10 in the cell membrane and its invaginations, the T-tubules. A small amount of Ca 2ϩ influx through these LTCCs triggers the release of much larger amount of Ca 2ϩ from the sarcoplasmic reticulum (SR) through activation of RyR2. This process is termed Ca 2ϩ -induced Ca 2ϩ release, and RyR2s are essential for this process.
LTCCs in T-tubules are in close proximity to the junctional SR that contains RyRs, and together they form a "couplon," 11 where Ca 2ϩ -induced Ca 2ϩ release takes place. SR Ca more LTCCs open, to raise local junctional cleft [Ca 2ϩ ], to promote binding to RyRs, to cause their opening. The resultant flux of SR Ca 2ϩ into the junctional space further elevates cleft Ca 2ϩ and this activates other nearby RyRs to induce locally regenerative Ca 2ϩ release. 12 In normal hearts, all couplons within a cell appear to be activated with each heart beat, 11 and it is the sum of the Ca 2ϩ release from all couplons that produces the systolic Ca 2ϩ transient that activates the contractile apparatus. 13 Relaxation occurs through Ca 2ϩ reuptake into the SR through the SR Ca 2ϩ
ATPase (SERCa) and Ca 2ϩ extrusion through the Na/Ca exchanger. 14, 15 Length-independent changes in the force of cardiac contraction (contractility) are critical to normal cardiac function and are largely brought about by altering the amplitude and duration of the systolic [Ca 2ϩ ] transient. Contractility is efficiently regulated in the normal heart and this primarily results from activation of adrenergic signaling pathways through protein kinase A (PKA). Ca 2ϩ regulatory PKA targets include the LTCC (to increase Ca 2ϩ current and SR Ca 2ϩ load), phospholamban (to increase the activity of SERCa, promote more rapid removal of Ca 2ϩ from the cytoplasm and to help increase SR Ca 2ϩ loading), 16 and RyR (to increase Ca 2ϩ dependent opening). 16, 17 The roles of PKA-mediated LTCC and SERCa regulation in the normal control of cardiac contractility are widely accepted. 18, 19 However, the independent role of PKA-mediated regulation of RyR2 activity as a major regulator of cardiac contractile strength is not broadly supported in the literature. 20 This effect is predicted from the fact that increasing the Ca 2ϩ -dependent opening probability of RyR2 should not increase the number of couplons that release stored Ca 2ϩ , since all couplons participate in normal EC coupling. [21] [22] [23] In cardiac disease, the contractile demands on the heart are persistently increased, and chronic activity of the sympathetic nervous system is needed to maintain cardiac output. 24 This heightened hyperadrenergic state of the stressed heart is thought to contribute to depression of contractility reserve and cardiac arrhythmias. 25 Many studies have shown that deranged Ca 2ϩ handling in heart failure involves altered SERCa activity and reduced LTCC abundance with increased activity. 6,26 -27 The Marks laboratory has proposed that abnormal PKA-mediated phosphorylation of RyR2 (at Serine 2808) is centrally involved in defective Ca 2ϩ handling in HF. 9, 28 PKA-mediated hyperphosphorylation of RyR at S2808 is proposed to increase RyR Ca 2ϩ -dependent opening (leak), leading to depletion of SR Ca 2ϩ stores. 9 Studies by the Marks group have shown that PKA-mediated hyperphosphorylation of RyR2 at serine-2808 is a critical mediator of normal cardiac contractility regulation 29, 30 and cardiac dysfunction after MI. 8 These ideas were explored in experiments with genetically modified mice in which Ser-2808 is mutated to alanine (S2808A), to eliminate PKA-mediated phosphorylation. 29 In previous studies, we 31 and others 32 were unable to show any alterations in sympathetic regulation of cardiac or myocyte function in RyR S2808A mice. Given the critical nature of this topic, we studied if prevention of RyR2 phosphorylation after MI preserved cardiac function and reduced premature death, consistent with the development of cardiac dysfunction after MI being dependent on PKA phosphorylation of a single amino acid on RyR2.
In the present study, we examined if the absence of PKA phosphorylation of RyR at Ser-2808 (RyRS2808A mice) reduced the damaging effects of MI on cardiac structure and function. Cardiac performance was compared before and after MI in wild-type (WT) and RyRS2808A mice. Isoproterenol (Iso) effects on L-type Ca 2ϩ current (I CaL ), contractions and [Ca 2ϩ ] I transients were also measured. Our results showed that both WT and S2808A mice have depressed pump function after MI, but we could not show a difference between groups. MI size was identical in both groups. L-type Ca 2ϩ current, contractions, and [Ca 2ϩ ] I transients were also not significantly different in WT versus S2808A mice myocytes either before or after MI. Iso effects on Ca 2ϩ current, contraction, and Ca 2ϩ transients were identical in WT and S2808A myocytes before and after MI at both low and high concentrations. These results strongly support the idea that PKA phosphorylation of RyR-S2808 plays little or no role in the development of cardiac dysfunction after MI in these mice.
Methods
All methods have been described in detail in previous reports and are described in detail in the Online Supplement. Briefly, myocardial infarction was induced in WT and S2808A mice by permanent occlusion of the left anterior descending coronary artery. 33 Cardiac function was measured with echocardiography. At the time of death, hearts were removed and used for functional studies (isovolumic hearts and isolated myocytes), tissue was used for Western or biochemical analyses, or hearts were fixed and processed for histological studies.
Results

Cardiac Function In Vivo After MI
MI was induced by permanent ligation of the left anterior descending coronary artery. Before MI, there was no significant difference in cardiac function or structure between WT and RyR-S2808A mice. Ejection fraction (EF), fractional shortening (FS), left ventricle internal diameter, and septum wall thickness were not different in WT and RyR-S2808A mice ( Figure 1 ). These data are consistent with those we have previously reported. 31 One week after MI, both groups of mice had significant decreases of EF (pre-MI versus 1 week ). There were significant changes in ventricular geometry and wall thickness after acute MI. The LV was dilated in all hearts and chamber size was significantly increased in the first week and 4 weeks after MI ( Figure 1C ). Septum wall thickness was decreased significantly in the first week after MI in both groups and became stable at the end of 4 weeks ( Figure 1D ). There were no significant differences in geometry or wall thickness between WT and S2808A mice after MI.
Survival and Cardiac Phenotype After MI
Animals were studied for 4 weeks after MI surgery. There was no significant difference in survival between WT and S2808A mice (87% of all animals survived the 4-week study interval). Heart weight was significantly greater in MI mice compared with sham mice (Figure 2A ), but there was no difference between control and S2808A hearts. Lung weight was also significantly increased after MI in S2808A mice, suggesting more severe heart failure. Liver weight was slightly increased in S2808A mice, but there was no significant difference between the groups 4 weeks after MI ( Figure  2B and 2C). These data show that after MI, both WT and S2808A mice had cardiac dysfunction with signs of acute HF. We were unable to show any significant benefit in survival, structure, or function in S2808A versus WT mice.
Infarct Length and Fibrosis Were Not Different in WT and S2808A Mice
Infarct length was measured 4 weeks after MI. There was no significant difference in infarct length between WT and S2808A mice (WT versus S2808A: 32.55Ϯ2.38% versus 26.55Ϯ3.03%) ( Figure 2D ). Representative examples of infarcted cardiac tissue and fixed heart tissue sections are shown in Online Figure I , A through C. We also measured fibrosis in noninfarcted (remote) zones of infarcted hearts. The collagen content in the remote zone was not significantly different in WT and S2808A infarcted hearts ( Figure 2E ). These data show that WT and S2808A mice had similar infarct size and fibrotic remodeling after MI.
Western Blot Analysis
If PKA-mediated RyR-S2808 phosphorylation plays a critical role in either the normal physiology of the mouse heart or in the progression of cardiac dysfunction after MI, then eliminating this site would be expected to induce adaptive alterations in other Ca 2ϩ regulatory proteins, as shown in other studies. 34 Ca 2ϩ regulatory proteins including the L-type Ca 2ϩ channel ␣1C subunit, phospholamban, total and phosphorylated at Thr-17 (PLBt, PT17), RyR2 total protein (RyRt), and RyR2 phosphorylated at S2808 (RyRp) were measured with Western analysis in sham and MI mice (representative blots are shown in Online Figure II) . Average data are shown in Figure 3 . There was no significant difference in the abundance of any of these Ca 2ϩ regulatory proteins between WT and S2808A mice either in sham or MI groups ( Figure 3 ). There was a significant increase of PLB phosphorylation at Threonine17 in both WT and S2808A hearts after MI, but there were no differences between the groups. An antibody against phosphorylated RyR-Ser2808 did not react to RyR-S2808A samples. RyR Ser2808 phosphorylation was significant in sham hearts and increased after MI (Online Figure II and Figure III ). These results show that there are no significant differences in Ca 2ϩ regulatory protein abundance or phosphorylation either before or after MI in WT versus S2808A hearts. These results are inconsistent with a significant role for Ser2808 phosphorylation in the normal physiology of the mouse heart or in the deranged structure and function after MI. 
LTCC Current (I Ca,L ) in S2808A Mice After MI
Elimination of a critical element in normal EC coupling or in the regulation of the contractile response to stress would be expected to have a major effect on baseline cardiac function.
If not, as we have shown in this and other studies, 31 then significant adaptation of related molecules would be needed to offset the defective or lost protein. An example would be the conditional NCX knockout mouse 34 that survives with adaptive reduction in the L-type Ca 2ϩ current density. If phosphorylation of RyR at Ser-2808 is critical to the regulation of EC coupling in health and disease, then its loss should either induce a significant basal phenotype (which it did not) or there should be adaptive changes in other EC coupling proteins. The major protein that would be expected to change would be the L-type Ca 2ϩ channel, with a known essential role in EC coupling. Therefore, we measured I Ca-L density and responsiveness to catecholamines. Peak I Ca,L density was not significantly different in WT and S2808A myocytes after sham operations (WT sham: Ϫ10.71Ϯ1.78 pA/pF, nϭ6; S2808A sham: Ϫ11.35Ϯ2.18 pA/pF, nϭ5). Isoproterenol (Iso) increased I Ca,L similarly in both WT and S2808A myocytes (sham WT after Iso: 16.55Ϯ0.58 pA/pF nϭ5; sham S2808A after Iso: 17.95Ϯ3.82 pA/pF, nϭ5) ( Figure 4A through 4C). Iso also caused similar hyperpolarizing shifts (a signature of PKA phosphorylation effect) in the voltage dependence of I Ca,L activation in sham control and S2808A myocytes (Online Figure III, A) . After MI, there was also no difference in peak I Ca,L in WT and S2808A myocytes (WT MI: Ϫ11.76Ϯ2.1pA/pF, nϭ7; S2808A MI: Ϫ9.00Ϯ0.98 pA/pF, nϭ7). Iso increased I Ca,L significantly in both WT (Ϫ16.2Ϯ2.7 pA/pF, nϭ7) and S2808A (Ϫ15.2Ϯ3.0 pA/pF, nϭ7) myocytes, but again no significant difference was detected between groups ( Figure 4A , 4B, and 4D). The voltage dependence of activation of I Ca,L in S2808A myocytes was not significantly different than control myocytes either before or after Iso treatment (Online Figure III, B) . Collectively, these data show that there are no significant changes in LTCC density or PKA regulation in RyR-S2808A mice either before or after MI.
Contractions and [Ca
2؉
] i Transients in WT and S2808A Mice Before and After MI Twitch contractions and [Ca 2ϩ ] i transients were studied at 0.5 and 2 Hz in the absence and presence of Iso (representative data are shown in Online Figure IV and V). Low and high concentrations of Iso were tested because others have suggested that differences in catecholamine responsiveness of WT and S2808A myocytes are only observed at low concentrations. 29 The rationale for this is unclear since the hyperphosphorylation hypothesis predicts that differences between WT and S2808A animals should be most robust when WT RyR is hyperphosphorylated. Nevertheless, we compared the effects of lower [Iso] on WT and RyR-S2808A animals and myocytes.
There were no significant differences in the amplitude of contraction (FS) do not support the hypothesis that the loss of PKA-mediated phosphorylation of RyR2 at S2808 has any effect on baseline cardiac myocyte function in the absence or presence of low or high [Iso] .
MI induced changes (half-width and tau) in the duration of contractions and [Ca 2ϩ ] i transients ( Figures 5 and 6 and Online Figures IV and V) . These changes were identical in WT and S2808A mice. Slowing and prolongation of contraction after MI probably results from changes in a host of processes, but changes in phosphorylation of RyR2 at S2808A do not appear to be a central element of this functional remodeling.
Low and high [Iso] was also tested in vivo (Online Figure  VI) , and we could not define a difference in effects in WT and S2808A animals. These results are similar to those we have shown previously in isolated hearts from these animals. 31 Collectively, these results suggest that PKA-mediated phosphorylation of RyR-S2808 is not critical modulator of myocyte function in health or disease, at least under our conditions.
SR Ca
2؉ Load in WT and S2808A Myocytes SR Ca 2ϩ load is often decreased in myocytes isolated from failing hearts, 35 and this is thought to be, at least in part, due to an abnormal "leak" of Ca 2ϩ from the SR. PKA-mediated hyperphosphorylation of RyR at S2808 has been proposed as the mechanism that leads to SR "leak" and a reduction in SR Ca 2ϩ stores in hyperadrenergic states, 36 but other studies suggest that CaMKII mediated RyR phosphorylation at an alternative site is the cause of this "leak." 37 In the present experiments, SR Ca 2ϩ load was measured as the caffeine releasable SR Ca 2ϩ transient (Figure 7 ). The effects of Iso on SR Ca 2ϩ load were determined in sham and MI myocytes ϮIso.
There were no significant differences in SR Ca 2ϩ load or the decay rate of these transients (not shown) between WT and S2808A myocytes under control conditions ( Figure 7C ). Iso caused a significant increase in SR Ca 2ϩ load in both WT and S2808A myocytes ( Figure 7C ), and the extent or rate of decay (not shown) was not different.
MI caused a significant reduction in SR Ca 2ϩ load in both WT and S2808A myocytes, and there were no differences between groups ( Figure 7C ). Iso had very small effects on SR Ca 2ϩ load in MI myocytes, and again there were no differences between groups ( Figure 7C ). These results do not support the hypothesis that hyperphosphorylation of RyR at S2808 is critical to the SR Ca 2ϩ leak that develops after MI. 
Discussion
The present study evaluated the hypothesis that PKAmediated phosphorylation of RyR-S2808 is critical for the normal regulation of cardiac contractility and that RyR hyperphosphorylation is critical for the cardiac dysfunction that develops after MI. Although the RyR hyperphosphorylation hypothesis has been supported by some previous studies, 8 the topic is still controversial, 38,39 and many critical issues have not been resolved. In the normal heart, contractility is primarily regulated by the sympathetic nervous system. To increase myocyte contractility, sympathetic signaling cascades activate PKA. The PKA target proteins that become phosphorylated include the LTCC, PLB, RyR, and troponin C. Increased myocyte contractility involves an increased amplitude and reduced duration of the systolic [Ca 2ϩ ] transient. The contribution of increased Ca 2ϩ influx through the phosphorylated LTCC complex and increased Ca 2ϩ uptake by the SR after PLB phosphorylation are well described in many laboratories. 40 The idea that PKA-mediated phosphorylation of RyR plays a critical role in the regulation of cardiac contractility is less well accepted and is not supported by modeling studies. 41 Studies with a S2808A mouse from the Marks group support a significant role for RyR2 phosphorylation at S2808 in the normal regulation of cardiac contractility 29, 30 and in the response of the heart to pathological stress. 8 The present results with a similar mouse are inconsistent with these previous reports.
MI reduces functional cardiac mass, and a hyperadrenergic state is required to maintain cardiac pump function. The persistent hyperadrenergic state eventually contributes to abnormal myocyte function 42 and death 43 that precipitates heart failure. The question posed here was if preventing phosphorylation of RyR2 at a single amino acid is sufficient to reduce adverse functional and structural remodeling after MI. Our results suggest that eliminating PKA-mediated phosphorylation at RyRS2808 has no impact on remodeling after MI, at odds with results of studies discussed below.
A number of reports 8, 17, 30, 44 strongly support the hypothesis that PKA-mediated phosphorylation of RyR at S2808 causes the RyR-associated protein FKBP12.6 (also called Calstabin) to dissociate from RyR and that this increases the Ca 2ϩ dependent opening of RyR. Hyperphosphorylation of RyR2 by PKA has been proposed as the cause of RyR "leak" that leads to reduced SR content and contractility in HF. 8 However, there is equally compelling data suggesting that PKA- mediated phosphorylation of RyR at S2808 has little or no role in the regulation of myocyte function in the normal or diseased heart. [31] [32] 38 There are studies showing that there are no appreciable differences in the level of phosphorylation of RyR2 and basal channel activity between failing and nonfailing canine hearts. 38 S2808A animals with pressure overload did not have better function than WT animals. 32 In addition, we have previously suggested that phosphorylation of RyR2 at Ser-2808 is not involved in the adrenergic regulation of normal cardiac contractility. 31 These data are consistent with a detailed modeling study from the Bers group 23 that predicts that increasing RyR Ca 2ϩ -mediated opening should have very little effect on contractility. In addition, others have shown that CaMKII-mediated phosphorylation of RyR at S2814 rather than PKA-mediated phosphorylation of S2808 is responsible for regulation of RyR function 45 and that PKA phosphorylation of RyR does not induce significant displacement of FKBP from RyR2. 46 The results we report in the present investigation are consistent with those that have been unable to document any significant role for RyRS2808 phosphorylation in health and disease.
We were unable to find any significant difference in any Ca 2ϩ regulatory process in S2808A mice. Our logic for looking at other molecules involved in EC coupling and the regulation of cardiac contractility in S2808A mice was that because everyone agrees that S2808A mice have no basal phenotype, either S2808 phosphorylation is unimportant or there are adaptive changes in other proteins involved in the regulation of myocyte Ca. An example of this in mouse models is the conditional cardiac Na/Ca 2ϩ exchanger (NCX) KO that was expected to die after eliminating the major Ca 2ϩ efflux mechanism in the normal heart, but did not die. 34 It was shown that these mice were able to live with a large reduction in Ca 2ϩ efflux by an adaptive reduction in Ca 2ϩ influx through the L-type Ca 2ϩ channel. 34 If RyR-S2808 phosphorylation is a critical component of the physiological regulation of cardiac contractile function, then related adaptations would be expected because there is no basal phenotype. We were unable to detect any change in abundance, phosphorylation, or function of any Ca 2ϩ regulatory protein involved in Ca 2ϩ entry or efflux and SR Ca 2ϩ uptake, storage, and release. We were unable to detect any beneficial effect of loss of RyRS2808 phosphorylation after MI. Importantly we were able to show reduced SR Ca 2ϩ loading in MI myocytes, but there were similar reductions in WT and S2808A myocytes. These results support the idea that alterations in SR Ca 2ϩ uptake, storage, and release are involved in post MI functional remodeling but do not support a role for hyperphosphorylation of RyR S2808 in these changes.
It is difficult to find common ground with those studies that have reported such strong evidence for the RyRS2808 hyperphosphorylation hypothesis. 8 A recent report 29 suggested that the reason for the differences between those studies finding and not finding different catecholamine effects in WT versus S2808A mice is related to the fact that studies not detecting differences used Iso concentrations that were too high. Interestingly, there were already data in the literature using low [Iso] that did not support this notion. A previous study 31 showed that exposing WT and RyR2808A isovolumic hearts to 10 nmol/L Iso caused identical increases in contractility in both groups, whereas when a 10-fold higher concentration (100 nmol/L) of Iso was used in the recent studies from the Marks laboratory, reduced Iso effects were seen in S2808A hearts. Because of this concentration issue, we tested the effects of lower [Iso] on isolated myocyte function and could not find any difference in effects in WT and S2808A cells. Therefore, our present and previous results do not support the idea that low doses of catecholamines are required to demonstrate differences in cardiac function related to RyR-S2808 phosphorylation. We are at a loss to find an explanation for the differences between our data and those studies documenting a critical role for this single amino acid in the regulation of cardiac function in health and disease. One potential explanation for the differences in the literature could be that the 2 sets of S2808A mice have a different genetic background.
In summary, our results do not support a major role of S2808 PKA phosphorylation on myocyte contractility regulation in health and disease.
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Novelty and Significance
What Is Known?
• After myocardial infarction (MI), sympathetic regulatory pathways are activated (with heightened activity of protein kinase A [PKA]) to increase the contractility of surviving myocytes and thereby maintain cardiac pump performance.
• Some studies propose that PKA-mediated hyperphosphorylation of a single serine (S2808) on the ryanodine receptor (RyR; responsible for Ca 2ϩ release from the sarcoplasmic reticulum [SR] is a critical determinant of myocyte contractile and electric dysfunction after MI.
• Other studies have suggested that phosphorylation of RyRS2808 is not an essential regulator of RyR function in health and disease.
What New Information Does This Article Contribute?
• Preventing phosphorylation of RyR at S2808 (with an alanine substitution; RyRS2808A) does not induce a significant change in cardiac function or in the contractile response to adrenergic agonists, at either low or high concentrations.
• MI induced similar reductions in cardiac function and myocyte adrenergic responsiveness in wild-type and RyRS2808A mice.
• Changes in Ca 2ϩ regulatory processes after MI, including a reduction in SR Ca 2ϩ stores, were similar in wild type and RyRS2808A mice, documenting the lack of functional benefit of preventing PKA phosphorylation of S2808 after MI.
MI causes regional cellular death in the heart and results in depressed cardiac pump function. Heightened adrenergic signaling with activation of PKA helps maintain cardiac function after MI but eventually causes myocyte dysfunction. Some investigators have suggested that PKA-mediated phosphorylation of RyR at S2808 is critical to the normal regulation of cardiac contractile function and that hyperphosphorylation of S2808 is responsible for SR disturbances that reduce contractility and promote arrhythmias in disease, making hyperphosphorylation of S2808 a therapeutic target. The results of our study show that RyRS2808 phosphorylation increases after MI and that SR Ca 2ϩ stores are reduced, consistent with SR Ca 2ϩ "leak" hypothesis. However, preventing RyRS2808 phosphorylation had no effect on adrenergic regulation of myocyte or heart function in the normal heart, and it did not prevent depressed function after MI or reductions in SR Ca 2ϩ loading after MI. Our results show that, at least under the experimental conditions used, PKA-mediated phosphorylation of RyR at S2808 is not a critical regulator of cardiac contractile function in the normal heart and that it might not be the mechanism that reduces SR Ca 2ϩ loading and myocyte contractility reserve after MI.
Detailed Methods
Mice and Experimental Protocol WT and RyR-S2808A mice were used in these studies. The methods used to generate the RyR-S2808A mouse have been described previously 1 . Experiments were performed based on the National Institutes of Health Guide for the Care and Use of Laboratory Animals, and all procedures were approved by the Temple University Committee on Animal Care. Myocardial infarction (MI) surgeries were carried out in mice at the age of 4 months. Mice were anesthetized with 2% isoflurane inhalation. A skin incision was made over the left thorax, and the pectoral muscles were retracted to expose the ribs. At the level of the fifth intercostal space, the heart was exposed and pumped out through an expanded space between ribs. A permanent knot or slipknot (for reperfusion purpose) was made around the left anterior descending coronary artery (LAD) 2-3 mm from its origin with a 6-0 silk suture. The heart was immediately placed back into the intrathoracic space after the knot was tied,, followed by manual evacuation of pneumothoraces and closure of muscle and the skin suture by means of the previously placed purse-string suture. Sham-operated animals were subjected to the same surgical procedures except that the suture was passed under the LAD but was not tied [2] [3] .
Determination of Left Ventricle Infarct Size After MI After mouse was anesthetized; heart was quickly removed and frozen in a dish placed on dry ice for a few minutes. Then the heart was quickly sliced into eight 1.2-mm-thick sections perpendicular to the long axis of the heart. The sections were incubated in PBS containing 2% triphenyltetrazolium chloride (TTC; Sigma) at room temperature for 15 min and digitally photographed. TTC-negative staining area (infarcted myocardium) and total circumference of section were measured by NIH Image J software. Myocardial infarction size (expressed as percentage) was calculated using infarct length divided by total circumference of tissue sections.
In-vivo Functional Analysis (Echocardiography, ECHO) ECHO was performed with
VisualSonics Velvo 770 machine which is specifically designed for mice and rats. Mice were anesthetized with 2% isoflurane initially and then 1% during the ECHO procedure. Hearts were viewed in the short-axis between the two papillary muscles and analyzed in M-mode. Parameters were to be measured offline (Velvo software) including enddiastolic diameter (EDD), end-systolic diameter (ESD), posterior wall thickness (PWT), and septal wall thickness (SWT) to determine cardiac morphological changes and ejection fraction (EF), heart rate and fractional shortening (FS).
Histology Animals were anesthetized by sodium pentobarbital (0.1ml/100g) and heparinized intravenously. Hearts were excised, trimmed off excess tissue, weighed, washed and then perfused with 10% buffered formalin. The fixed heart tissues were dehydrated, embedded in paraffin, sectioned at 5-μm thickness, and then perform Masson's Trichrome staning, which was used to evaluate gross morphology, fiber integrity or fibrosis. Images were acquired using SPOTINSIGHT software (Diagnostic Instruments Ins.). 3 fields were captured from each tissue section per heart and blue area were automatically analyzed using Metamorph 6.1 software (Universal Image Corp.). Average blue area percentage was calculated across at least 3 independent hearts. 
Cellular Functional Analysis
Myocyte Isolation
Mice were anesthetized with sodium pentobarbital (0.1ml/100g). The heart was excised, weighed and cannulated on a constant-flow langendorff apparatus. The heart was digested by retrograde perfusion of normal tyrode solution containing 180 U/mL collagenase and (mM): CaCl2 0.02, glucose 10, HEPES 5, KCl 5.4, MgCl2 1.2, NaCl 150, sodium pyruvate 2, pH 7.4. When the tissue has softened, left ventricular tissue is gently minced, filtered, and equilibrated in Tyrodes solution with 0.2 mM CaCl 2 , and 1% bovine serum alumin( BSA) at room temperature. Routinely, our initial yield is >90% rodshaped VMs, and >80% calcium-tolerant, rod-shaped VMS survive by the end of the isolation. ] i were measured in paced myocytes loaded with Fluo-4AM as described in previous studies 5 . Once a steady state had been reached, 10 and 100nM Isoproterenol (Iso) was applied through the perfusion solution. Once a stable effect of Iso had been achieved, at least 20 continuous contractions and Ca 2+ transients were recorded and averaged for analysis. Ca 2+ transients were fit with a singleexponential decay function to determine the decay rate. To measure SR Ca 2+ content, myocytes were paced at 0.5 Hz for 10 consecutive contractions, and 10 mM caffeine was then rapidly applied via a glass pipette close to the myocyte with a Pico spritzer [6] [7] . Since caffeine cannot be repetitively applied on the same cell, the SR Ca 2+ content after 10nM Iso was measured by a caffeine spritz after stable effects of Iso on myocyte contraction and Ca 2+ transients had been observed.
In vivo hemodynamic measurements Mice were anesthetized with a 2% Isoflurane and the right common carotid artery was isolated and cannulated with 1.4 French micromanometer (Millar Instruments, Houston, TX). LV pressure, LV end-diastolic pressure (LVEDP) and heart rate (HR) were measured by this catheter advanced into the LV cavity, and data was recorded and analyzed on a PowerLab System (AD Instruments Pty Ltd., Mountain View, CA). These parameters as well as maximal values of the instantaneous first derivative of LV pressure (+dP/dtmax, as a measure of cardiac contraction) and minimum values of the instantaneous first derivative of LV pressure (-dP/dtmin, as a measure of cardiac relaxation) were recorded at baseline and after administration of the β-adrenergic receptor (βAR) agonist, isoproterenol (Iso, 2ug/Kg and 2mg/Kg i.p. injection)
Western Blotting Cytoplasmic and membrane protein were isolated from ventricular tissue using PBS lysis buffer containing: 0.5% Triton X-100, 5 mM EDTA (pH7.4), phosphatase inhibitors (10 mM NaF and 0.1 mM NaVO4), proteinase inhibitors (10 μg/ml aprotinin, 10 μg/ml leupeptin, 1mM phenylmethylsulfonyl fluoride, 5 μg/ml pepstatin A, 8 μg/ml calpain inhibitor I & II, and 200 μg/ml benzamidine). Cardiac actin was isolated from resulting pellet using PBS lysis buffer containing 2% sodium dodecyl sulfate, SDS (FisherBiotech), 1% IGEPAL CA-630 (Sigma), 0.5 % deoxycholate (Sigma), 5 mM EDTA (pH 7.4), and proteinase inhibitors. Protein abundance and phosphorylation levels in isolated protein were analyzed with Western blot analysis as described previously 8 . Target antigens were probed with the following antibodies: phospholamban (PLB) (Upstate Biotechnology), RyR (Research Diagnostics), α-sarcomeric actin (Sigma), LTCC-α1C subunit (Chemicon), GAPDH (Serotec), PS2809-RyR, PS16-PLB, and PT17-PLB (Badrilla).
Statistics
Data are presented as mean±SEM. Between-group comparisons were performed by using the one way ANOVA or t-test. For all tests, statistical significance was set at P<0.05. 
WT S2808A
Dose of Isoproterenol Peak + dp/dt (mmHg/s) After Isoproterenol
